We are live on ! Find out more
ACET icon

Adicet Bio
ACET

96 hedge funds and large institutions have $177M invested in Adicet Bio in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 11

179% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 14

158% more capital invested

Capital invested by funds: $68.3M → $177M (+$108M)

68% more call options, than puts

Call options by funds: $109K | Put options by funds: $65K

26% more funds holding

Funds holding: 76 → 96 (+20)

0.48% more ownership

Funds ownership: 5.24% → 5.72% (+0.48%)

Holders
96
Holders Change
+20
Holders Change %
+26.32%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
39
Reduced
14
Closed
11
Calls
$109K
Puts
$65K
Net Calls
+$44K
Net Calls Change
+$130K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$19.5M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$16M
3
TCM
Tang Capital Management
California
+$14.3M
4
Goldman Sachs
Goldman Sachs
New York
+$10.3M
5
O
OrbiMed
New York
+$8.08M

Top Sellers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
-$4.8M
2
Morgan Stanley
Morgan Stanley
New York
-$3.96M
3
JJ
Johnson & Johnson
New Jersey
-$838K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$528K
5
OQS
Occudo Quantitative Strategies
Florida
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$26.9M +$8.08M +195,312 +38%
RCM
2
RA Capital Management
Massachusetts
$17.7M +$19.5M +471,313 New
TCM
3
Tang Capital Management
California
$15.1M +$14.3M +345,691 +631%
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$14.5M +$16M +386,354 New
RI
5
RTW Investments
New York
$9.72M – – –
Millennium Management
6
Millennium Management
New York
$9.65M +$7.2M +174,037 +211%
Morgan Stanley
7
Morgan Stanley
New York
$9.56M -$3.96M -95,644 -27%
Goldman Sachs
8
Goldman Sachs
New York
$9.41M +$10.3M +248,561 +13,902%
BlackRock
9
BlackRock
New York
$7.93M +$3.08M +74,410 +55%
Vanguard Group
10
Vanguard Group
Pennsylvania
$7.35M +$3.73M +90,094 +86%
CG
11
Carlyle Group
District of Columbia
$6.9M +$2.15M +52,083 +39%
CC
12
Commodore Capital
New York
$3.23M +$3.55M +85,895 New
Blackstone Inc
13
Blackstone Inc
New York
$2.91M +$3.2M +77,278 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.83M +$1.4M +33,948 +82%
SSA
15
Schonfeld Strategic Advisors
New York
$2.67M +$2.42M +58,394 +467%
Renaissance Technologies
16
Renaissance Technologies
New York
$2.46M +$730K +17,650 +37%
State Street
17
State Street
Massachusetts
$2.21M +$775K +18,731 +47%
CAC
18
Cowen and Company
New York
$2.02M -$4.8M -115,946 -68%
OCA
19
Octagon Capital Advisors
New York
$1.8M +$1.99M +47,987 New
WP
20
Woodline Partners
California
$1.73M +$1.9M +45,943 New
Alyeska Investment Group
21
Alyeska Investment Group
Illinois
$1.54M +$1.7M +40,979 New
DCM
22
DAFNA Capital Management
California
$1.41M +$1.55M +37,500 New
Two Sigma Investments
23
Two Sigma Investments
New York
$1.23M +$416K +10,053 +45%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$1.19M -$36.2K -875 -3%
Northern Trust
25
Northern Trust
Illinois
$1.02M +$526K +12,721 +88%
1
2 3 4 5

ACET Hedge Fund Activity: Q1 2024 in Review

96 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q1 2024, worth a combined $177M — up 158% from $68.3M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ACET positions and 11 closed out — a net gain of 20 holders — while 39 added to existing stakes and 14 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $19.5M. The largest seller was Cowen and Company, cutting an estimated $4.8M.

  • 96 institutional investors held Adicet Bio (ACET) as of Q1 2024, up from 76 in Q4 2023.
  • Funds reported $177M of Adicet Bio stock for Q1 2024, up 158% quarter-over-quarter.
  • 31 funds opened new Adicet Bio positions in Q1 2024 and 11 closed out, a net change of +20 holders.
  • The largest Adicet Bio buyer in Q1 2024 was RA Capital Management, an estimated $19.5M added.
  • The largest Adicet Bio seller in Q1 2024 was Cowen and Company, an estimated $4.8M sold.

Based on aggregated 13F filings for Q1 2024.